CV Therapeutics Appoints Joseph M. Davie, M.D., Ph.D. to Board of Directors
CV Therapeutics, Inc. announced that it has appointed Joseph M. Davie, M.D., Ph.D., to the company's board of directors.
Dr. Davie, former senior vice president of research at Biogen, Inc., also previously held senior level research positions with G.D. Searle & Co., and led the department of microbiology and immunology at the Washington University School of Medicine in St. Louis. He also has experience working in the laboratory of immunology at the National Institutes of Health, and is a member of the Institute of Medicine of the National Academy of Sciences.
He has authored or co-authored more than 175 publications and has served on the editorial board of journals such as Diabetes, American Journal of Pathology and Journal of Molecular and Cellular Immunology. Dr. Davie received his Ph.D. in bacteriology from Indiana University and his M.D. from Washington University School of Medicine.
Most read news
Other news from the department people
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.